The Naproxen Tablets, cataloged under National Stock Number 6505-01-204-5297, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Roche Laboratories Inc.. Government technical data includes 4 specifications, cited from the U.S. Government catalog. The record lists 2 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 1 additional reference document (drawings, advisory and superseded references) is recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-204-5297 |
| Primary Part Number | NDC00004-6311-14 |
| Item Name | Naproxen Tablets |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Roche Laboratories Inc. |
| Status | ACTIVE |
| Primary Container Content Quantity | 500.000 TABLETS |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | BOTTLE |
| Active Medicament Medicinal Strength | 375.000 MILLIGRAMS NAPROXEN ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| NDC00004-6311-14 PRIMARY | Roche Laboratories Inc. (USA) |
| NDC00781-1164-05 PRIMARY | Sandoz Consumer Health Care Group (USA) |
| Reference | Meaning |
|---|---|
| NAPROSYN | 5/1 Secondary reference Syntex Laboratories Inc |
NSN 6505-01-204-5297 is a Naproxen Tablets, manufactured by Roche Laboratories Inc., classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-204-5297 has 2 manufacturer part numbers on file: NDC00004-6311-14 (Roche Laboratories Inc.), NDC00781-1164-05 (Sandoz Consumer Health Care Group).
Key specifications for NDC00004-6311-14: Primary Container Content Quantity: 500.000 TABLETS; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: BOTTLE; Part Name Assigned by Controlling Agency: NAPROXEN TABLETS USP 375MG 500S. 4 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.